{"id":33409,"date":"2013-01-16T05:43:26","date_gmt":"2013-01-16T10:43:26","guid":{"rendered":"http:\/\/www.hedgeco.net\/news\/?p=33409"},"modified":"2013-01-16T05:43:26","modified_gmt":"2013-01-16T10:43:26","slug":"arena-pharma-investors-dea-hedge-funds-conspiring-to-destroy-belviq","status":"publish","type":"post","link":"https:\/\/hedgeco.net\/news\/01\/2013\/arena-pharma-investors-dea-hedge-funds-conspiring-to-destroy-belviq.html","title":{"rendered":"Arena Pharma Investors: DEA, Hedge Funds Conspiring To Destroy Belviq"},"content":{"rendered":"<p>TheStreet &#8211; Some of Arena Pharmaceuticals&#8217; retail-investor shareholders accuse the U.S. Drug Enforcement Agency of conspiring with Wall Street hedge funds to delay the commercial launch of the company&#8217;s weight-loss pill Belviq.<\/p>\n<p>The DEA is collecting public comments on its proposed rule making Belviq a Schedule IV controlled substance. The 30-day comment period ends on Jan. 18, after which DEA will finalize its ruling. After another 30-day waiting period, the rule becomes effective and Arena&#8217;s marketing partner Eisai can start selling Belviq and begin to compete against Vivus&#8217; Qsymia.<\/p>\n<p><a href=\"http:\/\/www.thestreet.com\/story\/11813587\/1\/arena-pharma-investors-dea-hedge-funds-conspiring-to-destroy-belviq.html\" target=\"_blank\"><strong>Read Complete Article<\/strong><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>TheStreet &#8211; Some of Arena Pharmaceuticals&#8217; retail-investor shareholders accuse the U.S. Drug Enforcement Agency of conspiring with Wall Street hedge funds to delay the commercial launch of the company&#8217;s weight-loss pill Belviq. The DEA is collecting public comments on its [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":["post-33409","post","type-post","status-publish","format-standard","hentry","category-syndicated"],"_links":{"self":[{"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/posts\/33409","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/comments?post=33409"}],"version-history":[{"count":1,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/posts\/33409\/revisions"}],"predecessor-version":[{"id":33410,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/posts\/33409\/revisions\/33410"}],"wp:attachment":[{"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/media?parent=33409"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/categories?post=33409"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/tags?post=33409"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}